| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/20/2006 | US7064123 substituted acetamides; uses for treating diseases including arthritis, muscular dystrophy, inflammation, tumor invasion, glomerulonephritis, malaria, periodontal disease, and metachromatic leukodystrophy |
| 06/20/2006 | US7064107 Prevention and reduction of blood loss |
| 06/20/2006 | US7063971 Phosphodiesterase enzymes |
| 06/20/2006 | US7063958 that encode a receptor for leptin, including a naturally occurring soluble form of the receptor that is expected to modulate, especially agonize, leptin activity; could be used to treat obesity |
| 06/20/2006 | US7063953 Human voltage gated sodium channel β1A subunit and methods of use |
| 06/20/2006 | CA2379633C Amino substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines |
| 06/20/2006 | CA2379585C Certain alkylene diamine-substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines |
| 06/20/2006 | CA2263404C Pharmaceutical composition comprising coenzyme q10 |
| 06/20/2006 | CA2121523C Sulfonamide derivatives |
| 06/15/2006 | WO2006062581A2 Delivery of therapeutic rnai agents for treating restenosis |
| 06/15/2006 | WO2006062465A1 Novel pyrrolo [3, 2-d] pyrimidin-4-one derivatives and their use in therapy |
| 06/15/2006 | WO2006062402A2 Heat shock proteins (hsp) and supraventricular arrhythmia |
| 06/15/2006 | WO2006062247A1 Substituted heterocyclic compound and thrombopoietin receptor activator |
| 06/15/2006 | WO2006062224A1 Carboxamide derivative |
| 06/15/2006 | WO2006062110A1 Piperazine derivative |
| 06/15/2006 | WO2006062104A1 Bacillus macroides strain and food using the same |
| 06/15/2006 | WO2006062087A1 Composition for treating or preventing myocardial disorder or heart failure |
| 06/15/2006 | WO2006061650A2 Methods, products and uses involving platelets and/or the vasculature |
| 06/15/2006 | WO2006061631A1 Method of producing a palatability enhancer that can add health value to foodstuffs |
| 06/15/2006 | WO2006061502A1 Tablets for the sustained release of indapamide and preparation method thereof |
| 06/15/2006 | WO2006061427A1 5-amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxypropxy)benzyl]-8-methylnonanamides |
| 06/15/2006 | WO2006061364A1 Process for the preparation of carvedilol and its enantiomers |
| 06/15/2006 | WO2006061341A1 Use of propionyl l-carnitine for the preparation of a high-dose medicament for the treatment of peripheral arterial disease |
| 06/15/2006 | US20060128787 Acyl-CoA: cholesterol acyltransferase and lipoxygenase inhibitors; superior oral absorbability; strong antihyperlipidemia effect and an anti-arteriosclerosis effect; N-(5-methanesulfonylamino-4,6-dimethyl-1-propylindolin-7-yl)-2,2-dimethylpropanamide |
| 06/15/2006 | US20060128780 Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 06/15/2006 | US20060128776 Opioid receptor active compounds |
| 06/15/2006 | US20060128768 Furanthiazole derivatives as heparanase inhibitors |
| 06/15/2006 | US20060128751 CETP inhibitors in combination with antihypertensive agents and uses thereof |
| 06/15/2006 | US20060128749 Compounds |
| 06/15/2006 | US20060128745 Chemical compounds |
| 06/15/2006 | US20060128736 Camptothecin-carboxylate formulations |
| 06/15/2006 | US20060128734 N-(4-(4-(4-hydroxyphenylamino)-pyrimidin-6-yl)-oxyphenyl)-N'-(3-trifluoromethylphenyl)-urea; |
| 06/15/2006 | US20060128701 N-{4-[ethyl-(2-hydroxy-ethyl)-amino]-phenyl}-2-[4-(2-oxo-4H-benzo[d][1,3]oxazin-1- yl)-piperidin-1-yl]-acetamide; Eating disorders; CNS disorders; antidiabetic agents; psychological disorders; antiepileptic, antiinflammatory agents, autoimmune diseases; neuropeptide Y5 (NPY5) receptor antagonists |
| 06/15/2006 | US20060128685 Pyrazole derivative |
| 06/15/2006 | US20060128656 Charged phospholipid compositions and methods for their use |
| 06/15/2006 | US20060128655 Use of hyaluronic acid or its derivatives to enhance delivery of antineoplastic agents |
| 06/15/2006 | US20060128643 Compositions containing a combination of a creatine compound and a second agent |
| 06/15/2006 | US20060128638 Treating atheroma, tumors and other neoplastic tissue; treating atherosclerotic inflammation; forming a complexes with a reducing agent, penetrate and accumulate more rapidly in tumor cells, plaque, increase drug in intracellular concentration; increase photosensitivity |
| 06/15/2006 | US20060128635 Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same |
| 06/15/2006 | US20060128633 Colchinol derivatives as vascular damaging agents |
| 06/15/2006 | US20060128629 Angiogenesis inhibitors, antitumor agents |
| 06/15/2006 | US20060128625 A growth factor formulation comprising: a polypeptide of the TGF- beta (tranformation growth factor) superfamily, N-vinyl-2-pyrrolidone polymer carrier and a solvent selected from water and aqueous buffer solutions |
| 06/15/2006 | US20060128619 Therapeutic use of modulators of notch |
| 06/15/2006 | US20060128607 Method for inhibiting "melanoma inhibitory activity" mia |
| 06/15/2006 | US20060128606 Fibrils |
| 06/15/2006 | US20060128013 Directed differentiation of embryonic cells |
| 06/15/2006 | US20060128003 Therapeutic agents for low HDL-cholesterolemia |
| 06/15/2006 | US20060127927 Mammalian IAP gene family, primers, probes, and detection methods |
| 06/15/2006 | US20060127890 Novel gene overexpressed in heart and skeletal muscle and use thereof |
| 06/15/2006 | US20060127508 Preparation for the relief of disease |
| 06/15/2006 | US20060127501 Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs |
| 06/15/2006 | US20060127494 Biologically active products |
| 06/15/2006 | US20060127464 Female hormone-containing patch |
| 06/15/2006 | US20060127445 Anti-angiogenic compositions and methods of use |
| 06/15/2006 | US20060127440 Drug delivery systems for the prevention and treatment of vascular diseases |
| 06/15/2006 | US20060127417 administering the toxin directly to a blood vessel, especially following a cardiovascular procedure. |
| 06/15/2006 | US20060127378 Composition for promoting the proliferation of lactobacillus casei subsp. casei |
| 06/15/2006 | US20060127367 Compositions containing macrophages and uses thereof |
| 06/15/2006 | US20060127361 Compositions and methods for inducing gene expression |
| 06/15/2006 | US20060127353 Fat-binding polymers |
| 06/15/2006 | US20060127319 dosage form of a mixture of drugs, foaming agents and gases, having improved pharmacokinetics; drug delivery systems |
| 06/15/2006 | CA2590252A1 5-amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxypropxy)benzyl]-8-methylnonanamides |
| 06/15/2006 | CA2590061A1 Hsp and supraventricular arrhythmia |
| 06/15/2006 | CA2589871A1 Materials and methods for treating and managing plaque disease |
| 06/15/2006 | CA2589699A1 Process for the preparation of carvedilol and its enantiomers |
| 06/14/2006 | EP1669463A1 Casein hydrolyzate, process for producing the same and use thereof |
| 06/14/2006 | EP1669462A1 Method of preparing alpha-glycosylisoquercitrin, intermediate therefor and by-product |
| 06/14/2006 | EP1669450A1 Staple type oligonucleotide and drug comprising the same |
| 06/14/2006 | EP1669446A1 Screening method |
| 06/14/2006 | EP1669352A1 Thiazoline derivative and use of the same |
| 06/14/2006 | EP1669350A1 Novel piperidine derivative |
| 06/14/2006 | EP1669345A1 Ester derivative and medicinal use thereof |
| 06/14/2006 | EP1669092A1 Preparation for the prophylaxis of restenose |
| 06/14/2006 | EP1669091A2 Therapeutic inhibitor of vascular smooth muscle cells |
| 06/14/2006 | EP1669089A1 INHIBITION OF NERVE CELL DEATH BY INHIBITING DEGRADATION OF SHC3, ATF6 OR CREBL1 BY HtrA2 AND METHOD OF AMELIORATING NEURODEGENERATIVE DISEASES |
| 06/14/2006 | EP1669083A1 Heat shock proteins (HSP) and supraventricular arrhythmia |
| 06/14/2006 | EP1669081A1 Apoptotic entities for use in treatment of T-cell-mediated und inflammatory disorders |
| 06/14/2006 | EP1669078A1 Cerebrovascular regeneration/reconstruction promoters and nerve tissue secondary degeneration inhibitors comprising ginsenoside RB 1 |
| 06/14/2006 | EP1669074A1 Use of megestrol acetate for improving heart function and the treatment of heart insufficiency |
| 06/14/2006 | EP1668001A1 Substituted heteroaryl benzofuran acids |
| 06/14/2006 | EP1667985A1 Substituted pyrimidines as ligands of adenosine receptors |
| 06/14/2006 | EP1667979A2 Isoquinoline potassium channel inhibitors |
| 06/14/2006 | EP1667978A2 Isoquinolinone potassium channel inhibitors |
| 06/14/2006 | EP1667976A1 Isoquinolinone potassium channel inhibitors |
| 06/14/2006 | EP1667970A1 Heterocyclic- or aryloxy, -thio 0r -amino substituted indoles-2-carboxylic acids or esters as pai-1 inhibitors |
| 06/14/2006 | EP1667969A1 Substituted sulfonamide-indole-2-carboxylic acid derivatives as pai-1 inhibitors |
| 06/14/2006 | EP1667962A1 Aminoalkylamide substituted cyclohexyl derivatives |
| 06/14/2006 | EP1667770A2 Novel derivatives of 4a,5,9,10,11,12-hexahydrobenzofuro [3a,3,2][ 2]- benzazepine, method for the production thereof and use thereof in the production of medicaments |
| 06/14/2006 | EP1667769A2 Use of galanthamine and the derivatives thereof in the production of medicaments |
| 06/14/2006 | EP1667721A2 Combinations of a vegf receptor inhibitor with other therapeutic agents |
| 06/14/2006 | EP1667635A2 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors |
| 06/14/2006 | EP1496884B1 Association of an antithrombotic agent with aspirin and use thereof for treating atherothrombotic diseases |
| 06/14/2006 | EP1476434B1 Pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same |
| 06/14/2006 | EP1476136B1 Pharmaceutical composition comprising n-((1-n-butyl-4-piperidinyl)menthyl)-3,4-dihydro-2h-(1,3)oxazino(3,2-a)indole-10-carboxamide or salt and process for preparing thereof comprising dry granulation |
| 06/14/2006 | EP1471931A4 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto |
| 06/14/2006 | EP1399439B1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
| 06/14/2006 | EP1393075A4 Methods of screening and using inhibitors of angiogenesis |
| 06/14/2006 | EP1381373B1 Medical compositions for use in the treatment or prevention of a functional vitamin b12 deficienfcy |
| 06/14/2006 | EP1347778B1 Behavior chemotherapy |
| 06/14/2006 | EP1341819B1 Use of fibrin/fibrinogen peptides and proteins for the manufacture of a medicament |